Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zentiva Group a.s.

http://www.zentiva.cz

Latest From Zentiva Group a.s.

Sobi To Go Private In $8.1bn Buyout That Appreciates Growth Strategy

Agnafit Bidco, comprised of Advent International and an affiliate of GIC Pte Ltd, will pay a premium for the rare disease specialist in an effort to capture value from Sobi’s planned growth.  

Deals Business Strategies

Zentiva Invests €27m In Prague Plant

Zentiva has announced that it is investing a further €27m in expanding its flagship manufacturing plant in Prague, having already pumped €35m into the site over the past three years.

Manufacturing Strategy

Mabxience Allies With Zentiva For European Bevacizumab Launch

Mabxience and Zentiva have partnered to launch the Alymsys bevacizumab biosimilar rival to Avastin that recently received a pan-European marketing authorization.

Biosimilars Launches

Zentiva's Zent2U Claims Advantage On EU Entresto Entry

Zentiva’s Zent2U B2B unit says that it will be ready to register for a European generic version of Novartis’ Entresto immediately upon data exclusivity expiry, putting its version in position for a “day one” launch once intellectual property protecting the cardiovascular blockbuster expires.

Generic Drugs Intellectual Property
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Solacium Pharma Creo Pharmaceuticals Ltd.
UsernamePublicRestriction

Register